Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes. Hawkins S Mult Scler. 2014 Aug; 20(9):1167-8. PMID: 27352434. Abstract CommentRecommendBookmarkWatch
